` 3613 (Beijing Tong Ren Tang Chinese Medicine Co Ltd) vs Hang Seng (Hong Kong) Comparison - Alpha Spread

3613
vs
Hang Seng (Hong Kong)

Over the past 12 months, has underperformed Hang Seng (Hong Kong), delivering a return of -6% compared to the Hang Seng (Hong Kong)'s 27% growth.

Stocks Performance
3613 vs Hang Seng (Hong Kong)

Loading
3613
Hang Seng (Hong Kong)
Add Stock

Performance Gap
3613 vs Hang Seng (Hong Kong)

Loading
3613
Hang Seng (Hong Kong)
Difference

Performance By Year
3613 vs Hang Seng (Hong Kong)

Loading
3613
Hang Seng (Hong Kong)
Add Stock

Competitors Performance
Beijing Tong Ren Tang Chinese Medicine Co Ltd vs Peers

Hang Seng (Hong Kong)
3613
LLY
JNJ
NOVO B
ROG
Add Stock

Beijing Tong Ren Tang Chinese Medicine Co Ltd
Glance View

Economic Moat
None
Market Cap
7.3B HKD
Industry
Pharmaceuticals

Beijing Tong Ren Tang Chinese Medicine Co., Ltd. engages in the manufacture, retail and wholesale of Chinese medicine and healthcare products. The company employs 745 full-time employees The company went IPO on 2013-05-07. Along with subsidiaries, it operates its business through three segments. The Hong Kong segment engages in the sale of Chinese medicine products and healthcare products and provision of Chinese medical consultation and treatments through retail outlets as well as wholesale of Chinese medicine products in Hong Kong. The company is also involved in the royalty fee income from overseas entities using the brand of Tong Ren Tang. The Mainland China segment engages in the wholesale of healthcare products in Mainland China and the sole distribution of Tong Ren Tang branded products of Tong Ren Tang Technologies and Tong Ren Tang Ltd. to customers outside Mainland China. The Overseas segment engages in the retail and wholesale of Chinese medicine products and healthcare products and the provision of Chinese medical consultation and treatments in other overseas countries.

Intrinsic Value
9.17 HKD
Undervaluation 4%
Intrinsic Value
Price
B
Back to Top